Catheter Precision

VTAK

Market cap $1.47M

VTAK Hedge Fund Activity: Q1 2026 in Review

12 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q1 2026, worth a combined $103K — down 18% from $125K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VTAK positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $80.8K. The largest seller was Millennium Management, cutting an estimated $36.6K.

• 12 institutional investors held Catheter Precision (VTAK) as of Q1 2026, up from 9 in Q4 2025.
• Funds reported $103K of Catheter Precision stock for Q1 2026, down 18% quarter-over-quarter.
• 6 funds opened new Catheter Precision positions in Q1 2026 and 2 closed out, a net change of +4 holders.
• The largest Catheter Precision buyer in Q1 2026 was Geode Capital Management, an estimated $80.8K added.
• The largest Catheter Precision seller in Q1 2026 was Millennium Management, an estimated $36.6K sold.

Based on aggregated 13F filings for Q1 2026.